Surmodics’ (SRDX) “Market Perform” Rating Reiterated at Barrington Research
Barrington Research restated their market perform rating on shares of Surmodics (NASDAQ:SRDX – Free Report) in a report released on Thursday, MarketBeat.com reports. Several other research firms have also recently weighed in on SRDX. StockNews.com cut Surmodics from a strong-buy rating to a buy rating in a report on Wednesday, April 24th. Lake Street Capital […]
More Stories
Accolade (NASDAQ:ACCD) Posts Quarterly Earnings Results, Beats Expectations By $0.14 EPS
Accolade (NASDAQ:ACCD – Get Free Report) announced its quarterly earnings data on Tuesday. The company reported ($0.30) earnings per share...
News from the WHO: Better use of vaccines could reduce antibiotic use by 2.5 billion doses annually, says WHO https://ift.tt/eG1fTLv October 10, 2024 at 07:00AM
Published on October 10, 2024 at 07:00AM View on website
MIDDLE EAST: Updating live from the Security Council and across the UN
As the crisis in the Middle East grinds on, we are covering the latest updates from the field and at...
Lakeland Financial Co. (NASDAQ:LKFN) to Issue $0.48 Quarterly Dividend
Lakeland Financial Co. (NASDAQ:LKFN – Get Free Report) declared a quarterly dividend on Tuesday, October 8th, Zacks reports. Investors of...
Brinker International (NYSE:EAT) Sets New 52-Week High After Analyst Upgrade
Brinker International, Inc. (NYSE:EAT – Get Free Report)’s share price hit a new 52-week high on Tuesday after Bank of...
Israeli forces fire on UN peacekeepers in Lebanon
Israel Defense Forces (IDF) fired on UN peacekeepers in Lebanon early Thursday morning, according to UNIFIL, the mission operating along...